Pharmaceutical Wholesalers’ Application for COVID-19 Collaboration


K&L Gates has advised Australia’s major pharmaceutical wholesalers API, Sigma, Symbion and National Pharmacies and their representative body, the National Pharmaceutical Services Association (NPSA), on an urgent Interim Authorisation application to the Australian Competition and Consumer Commission (ACCC).

The granting of the authorisation enables greater collaboration and assists in maximising efficiencies in the wholesalers’ supply chains as they provide medicines and pharmacy products to consumers, pharmacies and hospitals.

The ACCC continues to prioritise the processing of urgent applications for Interim Authorisation to assist businesses in responding to COVID-19 challenges. Recognising the significant public benefits of the industry collaboration, the ACCC granted Interim Authorisation within 48 hours of the wholesalers’ application, the eighth urgent application for Interim Authorisation the ACCC has processed, where commercial coordination was necessitated by COVID-19 challenges.

The K&L Gates team was led by Sydney policy and regulatory partner Ayman Guirguis (Picture), with lawyer Mei Gong assisting.

Involved fees earner: Mei Gong – K&L Gates; Ayman Guirguis – K&L Gates;

Law Firms: K&L Gates;

Clients: Australian Pharmaceutical Industries Limited; National Pharmaceutical Services Association (NPSA); National Pharmacies; Sigma Healthcare Limited; Symbion Ltd.;

Author: Michael Patrini